Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00689013 · ClinicalTrials.gov registry record · NA
The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting
A NA study, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 205
- Enrollment target
NCT00689013 is a NA study that has completed, run by University of Tennessee. The registered enrollment target is 205 participants.
The verdict
NCT00689013, a NA study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 205 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether pharmacist-driven patient interventions can have an effect on the number of herpes zoster (Zostavax) vaccinations given in a community pharmacy setting.
Interventions
- OTHER Personalized letter
- OTHER Flyer advertisement
- OTHER Newspaper press release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00689013
The ClinicalTrials.gov registry entry for NCT00689013 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Personalized letter is the first listed.
NCT00689013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00689013 about?
NCT00689013 is a clinical study titled "The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting". The purpose of this study is to determine whether pharmacist-driven patient interventions can have an effect on the number of herpes zoster (Zostavax) vaccinations given in a community pharmacy setting.
What is the current status of trial NCT00689013?
This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2008-02. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00689013?
The interventions under investigation include: Personalized letter (OTHER), Flyer advertisement (OTHER), Newspaper press release (OTHER).
Who is sponsoring clinical trial NCT00689013?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.